Kepler Capital analyst David Evans maintained a Buy rating on Merck KGaA (0O14 – Research Report) on March 6 and set a price target of ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...

FRANKFURT (Reuters) - Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by ...

Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced ...

Merck KGaA reaffirmed its strong performance in the healthcare sector in its FY 2024 earnings report, but provided little additional information on ongoing acquisition talks with SpringWorks ...

FRANKFURT, March 6 (Reuters) - Merck KGaA (MRCG.DE), opens new tab on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and ...

E Merck KG's board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board in a pivotal step in the company's ongoing growth strategy. Jean-Charles Wirth will ...

FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but ...

FRANKFURT (Reuters) - Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but it added that its strategy remains ...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. Blair, best known for her roles in turn ...